PCR Biosystems introduces kit for reliable quantification of libraries prepared for Illumina® NGS systems

Caption: PCR Biosystems NGSBIO Library Quant Kit for Illumina®.To download this image, please click here. London, UK (30 September 2020) – PCR Biosystems, the UK-based PCR experts, have expanded their range of specialist molecular biology kits with the introduction of NGSBIO Library Quant Kit for Illumina®. The new kit contains all the components necessary for accurate and sensitive quantification of DNA libraries... Read more

Bio-Techne Announces Grand Opening of GMP Manufacturing Facility

MINNEAPOLIS, Sept. 30, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the grand opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing Practices) manufacturing facility. Located in St. Paul, MN, the new facility is dedicated to supporting large-scale production of GMP-grade materials, including E. coli-derived recombinant proteins, which are an essential component for... Read more

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions Program will leverage Ion Torrent Genexus System* and Oncomine Precision Assay* to advance precision medicine for lung cancer in Asia CARLSBAD, Calif., Sept. 29, 2020 /PRNewswire/ — LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific’s Ion Torrent Genexus System* and Oncomine Precision... Read more

Zymo Research Granted CE IVD Mark for Sample Collection Devices

SAFE AND RELIABLE SAMPLE PRESERVATION AT AMBIENT TEMPERATURE FOR IVD APPLICATIONS Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices. IRVINE, Calif., (Sept. 25, 2020) — Zymo Research announced that three of its DNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection... Read more

BioTtechne Announces Commercial Release of New Co-detection Assays for Simultaneous Detection of RNA and Protein on the Same Sample

Expanding Bio-Techne’s lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS, Sept. 22, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables... Read more

Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership

MINNEAPOLIS, Sept. 17, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products.   The agreement grants QIAGEN a non-exclusive development license to Bio-Techne’s exosome... Read more

Fluidigm Joins Global Consortium of Cancer Prevention Experts

CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies Principal Focus on Advancing Understanding of Breast and Skin Cancer Risks SOUTH SAN FRANCISCO, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a... Read more

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

Hilden, Germany and Ann Arbor, Michigan, September 17, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology.... Read more

Targeted sequencing with Oxford Nanopore: Fast, flexible, PCR-free Cas9 Sequencing Kit now available in store

Wed 16th September 2020 New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequencing with nanopore enables fast, simple, flexible target enrichment of long regions of interest – read lengths of over 100 kb have been observed to date. The approach is amplification-free, opening up regions... Read more

Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test

 Fill Up Your Sanger Sequencers & Test to Capacity ANN ARBOR, Mich, (September 29th, 2020) Swift Biosciences, a leader in Next-Generation Sequencing Manufacturing & Technology and BillionToOne, a precision diagnostics company today announced that Swift Bioscience will be the exclusive distributor of BillionToOne’s RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity... Read more